- Q1 2024 Dynavax Technologies Corp Earnings Call TranscriptMay 08, 2024$11.65 (-0.94%)Earnings
- Q4 2023 Dynavax Technologies Corp Earnings Call TranscriptFeb 22, 2024$12.44 (-0.16%)Earnings
- Dynavax Technologies Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Dynavax Technologies Corp Earnings Call TranscriptNov 02, 2023$14.07 (-0.21%)Earnings
- Dynavax Technologies Corp at H.C. Wainwright & Co LLC 4th Annual Hepatitis B Virus (HBV) Conference (Virtual) TranscriptOct 25, 2023
- Q2 2023 Dynavax Technologies Corp Earnings Call TranscriptAug 03, 2023$13.39 (-1.11%)Earnings
- Dynavax Technologies Corp at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Dynavax Technologies Corp at William Blair Growth Stock Conference TranscriptJun 06, 2023
- Dynavax Technologies Corp at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 Dynavax Technologies Corp Earnings Call TranscriptMay 02, 2023$10.31 (-2.00%)Earnings
- Q4 2022 Dynavax Technologies Corp Earnings Call TranscriptFeb 23, 2023$10.77 (-1.19%)Earnings
- Q3 2022 Dynavax Technologies Corp Earnings Call TranscriptNov 03, 2022$11.17 (-0.89%)Earnings
- Q2 2022 Dynavax Technologies Corp Earnings Call TranscriptAug 04, 2022$14.34 (+1.49%)Earnings
- Q1 2022 Dynavax Technologies Corp Earnings Call TranscriptMay 05, 2022$8.76 (-6.21%)Earnings
- Q4 2021 Dynavax Technologies Corp Earnings Call TranscriptFeb 28, 2022$12.26 (-1.76%)Earnings
- Q3 2021 Dynavax Technologies Corp Earnings Call TranscriptNov 04, 2021$20.76 (-0.86%)Earnings
- Dynavax Technologies Corp at Guggenheim Vaccine and Infectious Disease Conference (Virtual) TranscriptOct 05, 2021
- Dynavax Technologies Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 Dynavax Technologies Corp Earnings Call TranscriptAug 04, 2021$9.88 (+1.44%)Earnings
- Dynavax Technologies Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Dynavax Technologies Corp Annual Shareholders Meeting TranscriptMay 28, 2021
- Q1 2021 Dynavax Technologies Corp Earnings Call TranscriptMay 06, 2021$8.88 (-0.67%)Earnings
- Dynavax Technologies Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Dynavax Technologies Corp Earnings Call TranscriptFeb 25, 2021$8.16 (-13.01%)Earnings
- Q3 2020 Dynavax Technologies Corp Earnings Call TranscriptNov 05, 2020$4.13Earnings
- Q2 2020 Dynavax Technologies Corp Earnings Call TranscriptAug 06, 2020$8.82 (-1.89%)Earnings
- Dynavax Technologies Corp Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 Dynavax Technologies Corp Earnings Call TranscriptMay 07, 2020$4.54 (-2.58%)Earnings
- Dynavax Technologies Corp - To Discuss the Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B - Conference Call TranscriptApr 30, 2020
- Q4 2019 Dynavax Technologies Corp Earnings Call TranscriptMar 11, 2020$3.07 (-18.13%)Earnings
- Q3 2019 Dynavax Technologies Corp Earnings Call TranscriptNov 06, 2019$5.23 (-2.43%)Earnings
- Q2 2019 Dynavax Technologies Corp Earnings Call TranscriptAug 07, 2019$2.99 (+3.82%)Earnings
- Q1 2019 Dynavax Technologies Corp Earnings Call TranscriptMay 08, 2019$6.53 (+0.31%)Earnings
- Q4 2018 Dynavax Technologies Corp Earnings Call TranscriptFeb 26, 2019$10.56 (+1.93%)Earnings
Dynavax Technologies Corp at Guggenheim Vaccine and Infectious Disease Conference (Virtual) Transcript
All right. Good afternoon, everyone, and thanks for joining us for today's fireside chat with Dynavax. I'm Evan Wang, a member of the Guggenheim biopharma team. I'm joined by Dynavax's Ryan Spencer, CEO; and Kelly MacDonald, CFO. Let me turn it over to Ryan quickly to start with a brief overview of Dynavax's pipeline, and then we'll jump into Q&A.
Great. Thanks, Evan. I'm going to share some slides here just to help facilitate the overview. So bear with me one second while I get this set up. Okay, thank you. So first, let's just start with a brief mention of our forward-looking statements. And we encourage you to review these as well as the risk factors on our most recent SEC filings.
So a quick overview for Dynavax. I think what you really need to understand right now is the Company is being built around two highly valuable assets, the first being HEPLISAV-B, which is our adult hepatitis B vaccine. And that vaccine is adjuvanted with CpG 1018,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)